We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOVT icon
1276
iShares US Treasury Bond ETF
GOVT
$43.6B
$208K ﹤0.01%
9,097
-905
-9% -$21K
VCLT icon
1277
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$208K ﹤0.01%
+2,649
New +$207K
VKTX icon
1278
Viking Therapeutics
VKTX
$3.7B
$207K ﹤0.01%
+12,751
New +$267K
EVLV icon
1279
Evolv Technologies
EVLV
$995M
$206K ﹤0.01%
+34,405
New +$163K
FTF
1280
Franklin Limited Duration Income Trust
FTF
$231M
$206K ﹤0.01%
33,362
-1,870
-5% -$11.6K
KOPN icon
1281
Kopin
KOPN
$652M
$204K ﹤0.01%
95,000
+2,000
+2% +$3K
UMH
1282
UMH Properties
UMH
$1.29B
$204K ﹤0.01%
12,763
-600
-4% -$9.29K
LDP icon
1283
Cohen & Steers Duration Preferred & Income Fund
LDP
$598M
$204K ﹤0.01%
+11,198
New +$196K
VUSB icon
1284
Vanguard Ultra-Short Bond ETF
VUSB
$8.94B
$203K ﹤0.01%
4,133
-526
-11% -$25.9K
IPAR icon
1285
Interparfums
IPAR
$3.99B
$203K ﹤0.01%
1,500
WLY icon
1286
John Wiley & Sons Class A
WLY
$2.65B
$201K ﹤0.01%
5,920
HYMB icon
1287
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.09B
$201K ﹤0.01%
+8,037
New +$200K
PGF icon
1288
Invesco Financial Preferred ETF
PGF
$677M
$199K ﹤0.01%
13,882
+202
+1% +$2.92K
KEY icon
1289
KeyCorp
KEY
$24.2B
$199K ﹤0.01%
+21,499
New +$224K
LMND icon
1290
Lemonade
LMND
$3.74B
$198K ﹤0.01%
+11,734
New +$184K
BANX
1291
ArrowMark Financial
BANX
$198M
$197K ﹤0.01%
+11,809
New +$200K
EMBJ
1292
Embraer S.A. ADS
EMBJ
$12.2B
$197K ﹤0.01%
+12,728
New +$194K
ADX icon
1293
Adams Diversified Equity Fund
ADX
$3.13B
$190K ﹤0.01%
11,288
FEI
1294
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$189K ﹤0.01%
24,526
+11,909
+94% +$90.9K
ENLC
1295
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$187K ﹤0.01%
17,595
MCRB icon
1296
Seres Therapeutics
MCRB
$46.8M
$186K ﹤0.01%
1,941
+85
+5% +$9.25K
NRK icon
1297
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
$184K ﹤0.01%
17,819
-900
-5% -$9.32K
XRN
1298
Chiron Real Estate Inc
XRN
$514M
$184K ﹤0.01%
4,037
-15,960
-80% -$721K
AUPH icon
1299
Aurinia Pharmaceuticals
AUPH
$1.91B
$183K ﹤0.01%
18,900
-2,500
-12% -$25.9K
ESBA icon
1300
Empire State Realty Series ES
ESBA
$1.34B
$181K ﹤0.01%
24,692
-60,000
-71% -$364K

Similar funds

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.